Exchange: NASDAQ·Updated 07:49 PM EST

GLSI News

News
all
press releases
Greenwich LifeSciences (NASDAQ:GLSI) Stock Rating Raised to "Hold" at Wall Street Zen
Wall Street Zen raised Greenwich LifeSciences from a "sell" rating to a "hold" rating in a research report on Saturday...
MarketBeat
Greenwich LifeSciences (NASDAQ:GLSI) Stock Rating Raised to "Hold" at Wall Street Zen
Wall Street Zen raised Greenwich LifeSciences from a "sell" rating to a "hold" rating in a research report on Saturday...
MarketBeat
More News
Greenwich LifeSciences, Inc. (NASDAQ:GLSI - Free Report) - Investment analysts at Noble Financial issued their FY2026 earnings per share estimates for shares of Greenwich LifeSciences in a research report issued on Wednesday, November 18th. Noble Financial analyst R. Leboyer expects that the company...
MarketBeat
Greenwich LifeSciences, Inc. (NASDAQ:GLSI - Free Report) - Research analysts at HC Wainwright dropped their FY2026 earnings per share estimates for shares of Greenwich LifeSciences in a research note issued to investors on Wednesday, November 18th. HC Wainwright analyst Y. Chen now forecasts that th...
MarketBeat
Greenwich LifeSciences: Buy Due To GLSI-100 BC Population Expansion And More...
SeekingAlpha
Greenwich said two research abstracts related to its experimental breast cancer drug were accepted for the San Antonio Breast Cancer Symposium, scheduled for December 8 to 11.
Stocktwits
Greenwich LifeSciences said the delay in filing Form 10-K was due to accounting adjustments tied to stronger-than-expected patient enrollment in its Phase III trial to treat breast cancer.
Stocktwits
Wall Street Zen lowered shares of Greenwich LifeSciences from a "hold" rating to a "sell" rating in a research note on Saturday...
MarketBeat
Greenwich LifeSciences, Inc. (NASDAQ:GLSI - Free Report) - Research analysts at HC Wainwright dropped their FY2026 EPS estimates for shares of Greenwich LifeSciences in a research report issued on...
MarketBeat
The company unveiled new Phase 3 data suggesting its breast cancer vaccine candidate could work across a broader patient population than initially targeted
Stocktwits
Greenwich LifeSciences (NASDAQ:GLSI) will be releasing earnings after the market closes on Tuesday, April 21. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-4-21-greenwich-lifesciences-inc-stock...
MarketBeat

Advertisement|Remove ads.